Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (11906)	12/11/2018 8:39:23 AM
From: Robohogs	Read Replies (1) \| Respond to of 12215

This xbi rip may finally hold. Data suggesting extreme os finally in an oscillator I track. Just time too.

To: scaram(o)uche who wrote (11906)	12/11/2018 11:14:38 AM
From: Miljenko Zuanic	Read Replies (3) \| Respond to of 12215

RE:MDGL "Target for launching trial is aggressive, 1Q19. You don't feel that they'll make it?" Many elements indicate that they can not effectively lunch P3 by 1Q/19. IF everything is done by CRO, who control it and who give green light? Maybe they can open trial with 1-2 site running, but that is not what is/was expected from +$3B EV program???!!! IF you are Roche (and know compound better than anyone else), at what point you will/would re-acquire assets back?